Medical Oncologist
CION Cancer Clinics
Systemic treatment for liver cancer: the options today | CION Cancer Clinics
For most people with advanced liver cancer and a liver that still works well, the usual first choice is an immunotherapy combination. Tablets such as lenvatinib and sorafenib are used when immunotherapy is not safe, or afterwards. This page explains each option, how your team chooses between them, and who these medicines do not suit. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What are the medicine options for advanced liver cancer today?
- Which systemic treatments are used for liver cancer?
- How does the team decide which medicine to start with?
- How do immunotherapy and tablets compare in daily life?
- Who do these medicines not suit?
- What this page cannot tell you
- Common questions about systemic treatment for liver cancer
The short answer
What are the medicine options for advanced liver cancer today?
For most people with advanced primary liver cancer and reasonably good liver function, the usual first choice today is an immunotherapy combination: atezolizumab plus bevacizumab, or durvalumab plus tremelimumab. Tablets such as lenvatinib and sorafenib remain important for people who cannot safely have immunotherapy, and other drugs follow if the first treatment stops working.
Which liver cancer this page is about
This page is about hepatocellular carcinoma (HCC), the cancer that starts in the liver cells themselves. If your report says the cancer began in the bowel, breast, lung or elsewhere and has spread to the liver, the medicines are chosen for that original cancer instead. Read why systemic treatment usually comes first in secondary cancer. Bile duct cancer inside the liver also has its own medicines.
What "systemic" means
Systemic treatment travels through the bloodstream and reaches cancer wherever it is. It is given as a drip into a vein or as tablets taken at home. It does not remove the tumour. The aim is to shrink it or hold it still, ease symptoms, and give you more good time.
At CION, immunotherapy, targeted therapy and chemotherapy are given at CION centres, after the tumour board has reviewed your scans and blood tests.The main families
Which systemic treatments are used for liver cancer?
There are four broad groups. Your oncologist chooses between them using your liver function, your other illnesses and what has been tried before.
Atezolizumab plus bevacizumab
An immunotherapy drug paired with a drug that cuts the tumour's blood supply, both given as a drip. It is the most common first choice when the liver is working well. Because bevacizumab can raise bleeding risk, an endoscopy to check for swollen veins in the food pipe usually comes first.
More detail: atezolizumab plus bevacizumab.Durvalumab plus tremelimumab
Two immunotherapy drugs, also by drip. It is an equally accepted first choice, and it suits some people for whom bevacizumab is a worry, such as those with a recent bleed. Availability of tremelimumab in India can vary, so ask your oncologist whether it can be supplied.
Targeted tablets
Lenvatinib and sorafenib are tablets taken at home. They block signals the tumour uses to grow and build blood vessels. They are used first when immunotherapy is not safe, and later if immunotherapy stops working.
Later options
Regorafenib, cabozantinib and ramucirumab are used after an earlier treatment has stopped working. Ramucirumab is only used when the AFP blood marker is very high. Immunotherapy on its own, and ordinary chemotherapy, have narrower roles.
Not sure whether this applies to you?
Ask an oncologistHow the choice is made
How does the team decide which medicine to start with?
Confirm it is advanced HCC
The tumour board looks at your scan, AFP and, where needed, a biopsy report. They check whether surgery, ablation or TACE could still do more than medicines. Medicines become the main plan when they cannot.
Measure the liver, not just the tumour
Blood tests for bilirubin, albumin and clotting, plus any fluid or confusion, give a Child-Pugh score. Most of the evidence for these drugs comes from people whose liver function is Child-Pugh A, meaning well preserved.
Check the safety questions
An endoscopy looks for varices before bevacizumab. Hepatitis B is controlled with antiviral tablets from a hepatologist or physician. Autoimmune illness and any past organ transplant are asked about, because immunotherapy can be unsafe with them.
Agree the first treatment and the review plan
You and your family hear the options, the likely side effects and the cost. Scans are repeated at set points to see whether it is working, and the plan changes if it is not.
Side by side
How do immunotherapy and tablets compare in daily life?
Immunotherapy combinations
Targeted tablets
Given as a drip at a CION centre, on a set schedule
Taken by mouth at home, with regular clinic checks
Side effects come from an overactive immune system, such as rash, diarrhoea, thyroid or liver inflammation
Side effects include sore hands and feet, high blood pressure, diarrhoea and tiredness
Usually the first choice when the liver works well
First choice when immunotherapy is not safe, or used next
Avoided after a liver transplant and in some autoimmune illness
Needs careful dose adjustment if side effects build up
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Not for everyone
Who do these medicines not suit?
Systemic treatment is not right for everyone with liver cancer. The main group it does not suit is people whose liver is failing. When cirrhosis is very advanced, with deep jaundice, fluid that keeps returning or repeated confusion, the drugs can do more harm than good. Good symptom and palliative care then becomes the main treatment, and it is real treatment.
When immunotherapy in particular is avoided
Immunotherapy is usually avoided after a liver or other organ transplant, because it can trigger rejection. Serious autoimmune illness is another reason for caution. Bevacizumab is avoided when there are large untreated varices or a recent bleed.
When another treatment may come first
If the cancer is small enough for surgery, ablation or a liver transplant, those offer a chance of curative treatment that medicines alone do not. Medicines are also not the first plan for most intermediate-stage cancers that TACE can reach. Some people with Child-Pugh B liver function can still be treated, carefully; see systemic treatment with Child-Pugh B.
Being straight with you
What this page cannot tell you
It cannot tell you which medicine is right for you. That depends on your scans, your blood results, your endoscopy and your other illnesses, read together by an oncologist who has seen them. Two people with the same stage can be offered different drugs for good reasons.
It cannot tell you how long treatment will work
Every person responds differently, and statistics from trials describe groups, not individuals. Your oncologist can tell you how they will judge whether it is working, and what the next step is if it is not.
It cannot give you a price
The cost depends on which drugs, for how long, and whether generic or biosimilar versions or assistance programmes apply. Ask for a written, itemised estimate. Drug supply in India also changes, so check what is available at the time you start.
If you have a scan report and are unsure whether medicines are the right next step, a second opinion from a medical oncologist can help you decide.Questions we are asked
Common questions about systemic treatment for liver cancer
Is sorafenib still used for liver cancer?
Yes. It is no longer the usual first choice for most people, because immunotherapy combinations have done better in trials. But sorafenib and lenvatinib remain important when immunotherapy is not safe, and as a later option. Many people take tablets at some point in their treatment.
Can these medicines remove the cancer completely?
Rarely. Their usual aim is to shrink or control the cancer and keep you well for longer. In a small number of people a tumour shrinks enough for surgery or another local treatment to be reconsidered, so your team keeps reviewing that question.
Why do I need an endoscopy before treatment?
People with cirrhosis often have swollen veins in the food pipe called varices. Bevacizumab can make bleeding from them more likely. An endoscopy shows whether they need banding first, which CION arranges through partner hospitals.
I have hepatitis B. Can I still have immunotherapy?
Usually yes. Hepatitis B is controlled with antiviral tablets that a hepatologist or physician manages. These are normally started or continued alongside cancer treatment to stop the virus flaring. Read more about immunotherapy with hepatitis B or cirrhosis.
What happens if the first treatment stops working?
A second treatment is usually possible if your liver function and strength allow it. After immunotherapy, a tablet such as lenvatinib or sorafenib is common. After a tablet, regorafenib, cabozantinib or ramucirumab may be considered. Your oncologist will explain the order for you.
Does ordinary chemotherapy help in liver cancer?
It helps less than people expect in HCC, and the newer drugs have largely replaced it. It still has a role in some bile duct cancers and in selected situations. Your oncologist will say plainly if it is being offered and why.
Are these drugs available in India?
Most of them are, and some have generic or biosimilar versions that can lower the cost. Supply of a few, such as tremelimumab, can vary. Your oncologist will confirm what can be given, and the team can help you look at assistance programmes.
How do I get an opinion on which option suits me?
Bring your latest scan with its report, your blood tests, any endoscopy report and the list of medicines you take. Call the CION helpline and ask for a medical oncology appointment. The tumour board can review your case and explain the options.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Immunotherapy for Liver Cancer
- American Cancer Society — Targeted Drug Therapy for Liver Cancer
- National Cancer Institute — Liver Cancer Treatment
- American Cancer Society — Treatment of Liver Cancer, by Stage
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
When tablets or infusions become the main treatmentThe point at which medicines take over from local treatmentChoosing between immunotherapy and tabletsThe first-line decision, in more depthWho cannot have atezolizumab plus bevacizumabThe safety checks that rule the usual first choice outSecond-line treatment after first-line failsWhat comes next if the first medicine stops working
Talk to us
Not sure which medicine your scan points to?
Send us your latest scan report and blood tests, and a medical oncologist can explain the options that fit your liver and your stage. One helpline serves every CION centre.